You are here

Novartis

Novartis’ Cosentyx Narrowly Misses Beating Out AbbVie’s Humira in Arthritis Trial

BioSpace

Fri, 11/1/19 - 11:50 am

psoriatic arthritis

Novartis Admits to ‘Mistake’ After Partial Clinical Hold Placed on Zolgensma Trial

RAPS.org

Thu, 10/31/19 - 11:54 pm

clinical trials

Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma

BioSpace

Thu, 10/31/19 - 10:37 am

Elizabeth Holmes

Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns

Stat

Wed, 10/30/19 - 10:32 am

clinical trials

Trials of Novartis' Dupixent rival bet scrapped by MorphoSys, Galapagos

Fierce Biotech

Tue, 10/29/19 - 09:57 am

atopic dermatitis

Novartis sends second wagon after KRAS gold rush

Endpoints

Fri, 10/25/19 - 10:46 am

Novartis bets $80M on Pliant's preclinical NASH prospect

Fierce Biotech

Wed, 10/23/19 - 10:39 pm

Pliant Therapeutics

Novartis downplays late-stage asthma drug failures

BioSpace

Wed, 10/23/19 - 10:31 pm

clinical tirals

Novartis Earnings Top; Swiss Drug Giant Edges Lower

Investors Business Daily

Tue, 10/22/19 - 10:48 am

Zolgensma hits the ground running, says Novartis

Pharmaforum

Tue, 10/22/19 - 10:33 am

Novartis' asthma drug fails in phase 3, raising doubts about Gossamer's prospects

Fierce Biotech

Tue, 10/22/19 - 10:28 am

clinical trials

Upcoming events – Novartis’s asthma Zeal and Alnylam's lumasiran test

EP Vantage

Sat, 10/19/19 - 01:36 pm

Primary Hyperoxaluria

Novartis takes a step back from marketing Pear prescription digital therapeutics

Biopharma Dive

Wed, 10/16/19 - 06:57 pm

Pear Therapeutics

digital therapeutics

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings

Yahoo/Benzinga

Mon, 10/14/19 - 09:43 am

Flexion Therapeutics

Clearside Biomedical

Assertio Therapeutics

Aldeyra Therapeutics

Lineage Therapeutics

Employees’ Perception vs. Employers’ Reality! New Research Shows the Top 3 Areas of Opportunity

BioSpace

Mon, 10/14/19 - 09:30 am

Novartis' ligelizumab outperforms Roche's Xolair in chronic urticaria clearance

Pharmafile

Wed, 10/9/19 - 11:10 pm

clinical trials

chronic urticaria

Eylea casts a shadow over Novartis' latest approval

Biopharma Dive

Wed, 10/9/19 - 11:04 pm

wet age-related macular degeneration

Biopharma M&A: deal-depressed third quarter leaves nowhere to hide

EP Vantage

Tue, 10/8/19 - 10:53 am

Alder Biopharmaceuticals

Gilead Sciences

Vertex Pharmaceuticals

Swedish Orphan Biovitrum

Dova Pharmaceuticals

Novartis’ new eye drug undercuts Bayer’s rival with fewer injections

Pharmaforum

Tue, 10/8/19 - 09:27 am

wet age-related macular degeneration

Recent Job Cuts in the Biopharma Industry

BioSpace

Mon, 10/7/19 - 11:29 pm

Integra Life Sciences

Roche Molecular Systems

Prometheus Labs

Pages